NVRO Company Profile and Key Details
Nevro Corp.
NVRO Stock Price Chart
Stock Price Today
Nevro Corp. (NVRO) stock surged +3.36%, trading at $5.23 on NYSE, up from the previous close of $5.06. The stock opened at $5.16, fluctuating between $5.16 and $5.47 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Company Information
| Employees | 1215 |
| Beta | 0.93 |
| Sales or Revenue | $425.17M |
| 5Y Sales Change% | -0.083% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Nevro Corp. (NYSE: NVRO) stock price is $5.23 in the last trading session. During the trading session, NVRO stock reached the peak price of $5.47 while $5.16 was the lowest point it dropped to. The percentage change in NVRO stock occurred in the recent session was 3.36% while the dollar amount for the price change in NVRO stock was $0.17.
The NYSE listed NVRO is part of Medical - Devices industry that operates in the broader Healthcare sector. Nevro Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Meredith Vornholt
Vice President of Global Marketing
Mr. D. Keith Grossman
Chairman, Chief Executive Officer & Pres
Mr. Roderick H. MacLeod
Senior Vice President & Chief Financial Officer
Ms. Niamh Louise Pellegrini
Senior Vice President & Chief Commercial Officer
Ms. Julie D. Dewey
Chief Communications & Investor Relations Officer
Mr. Patrick Schmitz
Vice President of Operations
Mr. Richard B. Carter
Chief Accounting Officer
Mr. Kashif Rashid
Senior Vice President, Gen. Counsel, Corporation Sec. & Chief Compliance Officer
Ms. Lori M. Ciano
Senior Vice President & Chief HR Officer
Dr. David Caraway M.D., Ph.D.
Senior Vice President & Chief Medical Officer
Mr. Michael Collier Carter
Vice President of Global Sales
Mr. Jon R. Shear
Senior Vice President of Corporation Devel.
Mr. Donald A. Middlebrook
Senior Vice President of Clinical & Regulatory Affairs
Mr. Christofer Christoforou
Senior Vice President of Technical Operations
Mr. Kevin R. Thornal
Group Pres of Global Diagnostic Solutions
NVRO's closing price is 59.87% higher than its 52-week low of $3.17 where as its distance from 52-week high of $17.75 is -71.49%.
Number of NVRO employees currently stands at 1,215.
Official Website of NVRO is: https://www.nevro.com
NVRO could be contacted at phone 650 251 0005 and can also be accessed through its website. NVRO operates from 1800 Bridge Parkway, Redwood City, CA 94065, United States.
NVRO stock volume for the day was 367.09K shares. The average number of NVRO shares traded daily for last 3 months was 596.04K.
The market value of NVRO currently stands at $195.98M with its latest stock price at $5.23 and 37.47M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com